speb/financial-data huggingface dataset:
Financial ratios for CNQ.TO — quarterly report dated 2025-09-30
Total revenue: 7964028776.978417
Gross profit: 1002877697.8417267
Operating income: 779856115.1079137
Net income: 431654676.25899285
Capital expenditures: 1482733812.9496403
Operating cash flow: 2834532374.1007195
Depreciation & amortization: 2310071942.4460435
Net tangible assets: 29108633093.52518
Owner earnings: 1258992805.755396
Return on net tangible assets (%): 4.325152616099454
Capex to operating income (%): 190.1291512915129
Buffett classification: The Gruesome
Stock price: 30.98561151079137
P/E ratio: 13.630849577628963
Shares outstanding: 2085710000
Book value: 29108633093.52518
P/B ratio: 2.2202004325152616
Market cap (USD): 64626999784.17267
Debt to equity: 0.42678134499888787
Current ratio: 0.863827739684831
Quick ratio: 0.5307349933838565
Effective tax rate (%): -23.20328542094456
Interest coverage ratio: 11.655913978494624
COGS to revenue (%): 87.4074074074074
SG&A to revenue (%): 1.9421860885275521
Free cash flow (dilution-adjusted): 1306474820.143885
Buyback yield (%): 0.34397722161910377
Retained earnings: 20797841726.618706
Inventory turnover: 3.4944023113037197
Receivables turnover: 2.9559412550066755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.402764118225581
FCF margin (%): 16.404697380307137
Revenue growth (%): 12.772293792872686
Rule of 40 score: 29.17699117317982
Financial ratios for CNQ.TO — annual report dated 2025-12-31
Total revenue: 32238686131.38686
Gross profit: 6862043795.620438
Operating income: 6004379562.043796
Net income: 7897810218.978102
Capital expenditures: 83941605.83941606
Operating cash flow: 11026277372.262774
Depreciation & amortization: 5552554744.525547
Net tangible assets: 32383941605.839413
Owner earnings: 13366423357.664232
Return on net tangible assets (%): 41.27485011044493
Capex to operating income (%): 1.3980063214198881
Buffett classification: The Great
Stock price: 33.277372262773724
P/E ratio: 8.788125591497229
Shares outstanding: 2085710000
Book value: 32383941605.839417
P/B ratio: 2.143252015056575
Market cap (USD): 69406948102.18979
Debt to equity: 0.37454356939999095
Current ratio: 0.9505146967629914
Quick ratio: 0.6254495845218901
Effective tax rate (%): 18.284117513782945
Interest coverage ratio: 7.917228103946102
COGS to revenue (%): 78.7148776235651
SG&A to revenue (%): 1.7999864151968663
Free cash flow (dilution-adjusted): 5937956204.379561
Buyback yield (%): 1.5238593001084182
Retained earnings: 23887591240.87591
Inventory turnover: 13.26440289965662
Receivables turnover: 11.044511127781947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.820096219274893
FCF margin (%): 18.418728915253467
Revenue growth (%): 11.063434840355606
Rule of 40 score: 29.482163755609072
Financial ratios for CNQ.TO — quarterly report dated 2025-12-31
Total revenue: 7817518248.175182
Gross profit: 1562773722.627737
Operating income: 1309489051.0948904
Net income: 3870802919.708029
Capital expenditures: 3649635.03649635
Operating cash flow: 2750364963.503649
Depreciation & amortization: 1852554744.5255473
Net tangible assets: 32383941605.839413
Owner earnings: 5719708029.19708
Return on net tangible assets (%): 17.66217373664518
Capex to operating income (%): 0.2787068004459309
Buffett classification: The Great
Stock price: 33.277372262773724
P/E ratio: 8.87985064116542
Shares outstanding: 2085710000
Book value: 32383941605.839417
P/B ratio: 2.143252015056575
Market cap (USD): 69406948102.18979
Debt to equity: 0.37454356939999095
Current ratio: 0.9505146967629914
Quick ratio: 0.6254495845218901
Effective tax rate (%): 22.561331775700932
Interest coverage ratio: 7.322448979591836
COGS to revenue (%): 80.00933706816059
SG&A to revenue (%): 2.26890756302521
Free cash flow (dilution-adjusted): 1628467153.2846713
Buyback yield (%): 0.30918884350025877
Retained earnings: 23887591240.87591
Inventory turnover: 3.269362838611217
Receivables turnover: 2.6781695423855965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.141654828273664
FCF margin (%): 20.83099906629318
Revenue growth (%): -1.839653433030684
Rule of 40 score: 18.991345633262497
Financial ratios for CTRM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.2
Shares outstanding: 9662354
Market cap (USD): 137205426.79999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTRM — annual report dated 2022-12-31
Total revenue: 159804393.6170213
Gross profit: 92234108.5106383
Operating income: 77759281.91489363
Net income: 126128393.61702128
Capital expenditures: 80375770.21276596
Operating cash flow: 101782498.93617022
Depreciation & amortization: 19718337.234042555
Net tangible assets: 490952191.4893617
Owner earnings: 65470960.638297886
Return on net tangible assets (%): 13.335506343231499
Capex to operating income (%): 103.36485655916428
Buffett classification: The Gruesome
Stock price: 11.2
P/E ratio: 0.8580016100783489
Shares outstanding: 9662354
Book value: 490952191.48936176
P/B ratio: 0.22042546438525254
Market cap (USD): 108218364.8
Debt to equity: 0.3007004278659017
Current ratio: 3.2268046738524205
Quick ratio: 3.1892060714575985
Effective tax rate (%): 0.5807132193271635
Interest coverage ratio: 10.723603915581121
COGS to revenue (%): 42.28312099373083
SG&A to revenue (%): 4.689201485885703
Free cash flow (dilution-adjusted): 21406728.723404255
Buyback yield (%): 0
Retained earnings: 167810941.4893617
Inventory turnover: 32.74549064308763
Receivables turnover: 27.965980115381726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.568579026761437
FCF margin (%): 13.395582085625557
Rule of 40 score: 13.395582085625557
Financial ratios for CTRM — annual report dated 2023-12-31
Total revenue: 108350567.77777778
Gross profit: 31636471.111111112
Operating income: 17360062.22222222
Net income: 42936097.777777776
Capital expenditures: 69982385.55555555
Operating cash flow: 24648183.333333332
Depreciation & amortization: 24529812.22222222
Net tangible assets: 567477490
Owner earnings: -2516475.5555555522
Return on net tangible assets (%): -0.4434494054655017
Capex to operating income (%): 403.12289587287705
Buffett classification: The Gruesome
Stock price: 4.25
P/E ratio: 0.9564214408244107
Shares outstanding: 9662354
Book value: 567477490
P/B ratio: 0.07236411174652936
Market cap (USD): 41065004.5
Debt to equity: 0.16327448806236644
Current ratio: 8.470509743309616
Quick ratio: 8.436329424989431
Effective tax rate (%): 0.8276822021372426
Interest coverage ratio: 1.5899442290187187
COGS to revenue (%): 70.80174865719569
SG&A to revenue (%): 5.826120318438366
Free cash flow (dilution-adjusted): 23955646.666666668
Buyback yield (%): 0
Retained earnings: 216358621.1111111
Inventory turnover: 70.62186246661601
Receivables turnover: 11.385259566562645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7104412085455274
FCF margin (%): 22.109387295319614
Revenue growth (%): -32.1980044945166
Rule of 40 score: -10.088617199196989
Financial ratios for CTRM — quarterly report dated 2024-09-30
Total revenue: 14900041.11111111
Gross profit: 3945401.111111111
Operating income: 1107071.111111111
Net income: 3151616.6666666665
Capital expenditures: 33589388.88888889
Operating cash flow: 8565208.888888888
Depreciation & amortization: 4067748.888888889
Net tangible assets: 617544771.111111
Owner earnings: -26370023.333333332
Return on net tangible assets (%): -4.2701395213641495
Capex to operating income (%): 3034.0769036215684
Buffett classification: The Gruesome
Stock price: 4.22
P/E ratio: 3.234461721761847
Shares outstanding: 9662354
Book value: 617544771.1111112
P/B ratio: 0.06602781820439634
Market cap (USD): 40775133.879999995
Debt to equity: 0.002908694191770106
Current ratio: 32.197640110840915
Quick ratio: 32.060252804466614
Effective tax rate (%): 0.17870635322553
Interest coverage ratio: 1.6542570765876976
COGS to revenue (%): 73.52087097149695
SG&A to revenue (%): 11.207418741648514
Free cash flow (dilution-adjusted): -25024180
Buyback yield (%): 0
Retained earnings: 267181396.66666666
Inventory turnover: 9.667650182239651
Receivables turnover: 7.122992115862769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1792697732861092
FCF margin (%): -167.94705338993472
Rule of 40 score: -167.94705338993472
Financial ratios for CTRM — quarterly report dated 2024-12-31
Total revenue: 16837047.916666668
Gross profit: 3634282.291666667
Operating income: 809794.7916666667
Net income: -12433441.666666668
Capital expenditures: 43654938.54166667
Operating cash flow: 10785926.041666668
Depreciation & amortization: 4154351.041666667
Net tangible assets: 555072281.25
Owner earnings: -51934029.16666667
Return on net tangible assets (%): -9.356264205755936
Capex to operating income (%): 5390.864326481889
Buffett classification: The Gruesome
Stock price: 2.75
Shares outstanding: 9662354
Book value: 651526793.75
P/B ratio: 0.04078339333838026
Market cap (USD): 26571473.5
Debt to equity: 0.17797909155443695
Current ratio: 3.9417886321008027
Quick ratio: 3.9176858529619945
Interest coverage ratio: 2.0032803782871427
COGS to revenue (%): 78.41496734074646
SG&A to revenue (%): 8.886362081238756
Free cash flow (dilution-adjusted): -32875033.333333336
Buyback yield (%): 0
Retained earnings: 238049117.70833334
Inventory turnover: 8.165280732247519
Receivables turnover: 0.7704887634515011
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.10606130574120867
FCF margin (%): -195.25414132005275
Revenue growth (%): 13.000009806087801
Rule of 40 score: -182.25413151396495
Financial ratios for CTRM — annual report dated 2024-12-31
Total revenue: 69003519.79166667
Gross profit: 20470070.833333336
Operating income: 8866145.833333334
Net income: 35212910.41666667
Capital expenditures: 37183010.41666667
Operating cash flow: 43657602.083333336
Depreciation & amortization: 15663547.916666668
Net tangible assets: 555072281.25
Owner earnings: 13693447.916666672
Return on net tangible assets (%): 2.4669666238475445
Capex to operating income (%): 419.3818950831228
Buffett classification: The Gruesome
Stock price: 2.75
P/E ratio: 0.7545946411581878
Shares outstanding: 9662354
Book value: 651526793.75
P/B ratio: 0.04078339333838026
Market cap (USD): 26571473.5
Debt to equity: 0.17797909155443695
Current ratio: 3.9417886321008027
Quick ratio: 3.9176858529619945
Effective tax rate (%): 0.8678585201738827
Interest coverage ratio: 2.101996791994557
COGS to revenue (%): 70.33474394474956
SG&A to revenue (%): 9.550151419661125
Free cash flow (dilution-adjusted): -31530896.875
Buyback yield (%): 0
Retained earnings: 238049117.70833334
Inventory turnover: 30.01562300694084
Receivables turnover: 3.1577053709904814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1612262929475414
FCF margin (%): -45.6946210428064
Revenue growth (%): -36.31457480389965
Rule of 40 score: -82.00919584670606
Financial ratios for CTRM — quarterly report dated 2025-03-31
Total revenue: 22113216.304347824
Gross profit: 5854770.652173913
Operating income: -33525
Net income: -20745416.304347824
Capital expenditures: 33067807.608695652
Operating cash flow: -1886181.5217391304
Depreciation & amortization: 3749361.956521739
Net tangible assets: 559916005.4347826
Owner earnings: -50063861.956521735
Return on net tangible assets (%): -8.941316460072693
Buffett classification: The Gruesome
Stock price: 2.28
Shares outstanding: 9662354
Book value: 663738748.9130435
P/B ratio: 0.03319102155189402
Market cap (USD): 22030167.119999997
Debt to equity: 0.09013999351358856
Current ratio: 2.318584256970123
Quick ratio: 2.318584256970123
COGS to revenue (%): 73.52365855968782
SG&A to revenue (%): 20.315590337256015
Free cash flow (dilution-adjusted): -2182584.7826086953
Buyback yield (%): 0
Retained earnings: 225520470.6521739
Receivables turnover: 2.5357855956687563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.00488082370605772
FCF margin (%): -9.87004672938311
Revenue growth (%): 31.336659572361135
Rule of 40 score: 21.466612842978023
Financial ratios for CTRM — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.14
Shares outstanding: 9662354
Market cap (USD): 20677437.560000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTRM — quarterly report dated 2025-09-30
Total revenue: 24662589.411764707
Gross profit: 7944875.294117647
Operating income: 1531122.3529411766
Net income: 24701038.82352941
Capital expenditures: 404152.9411764706
Operating cash flow: 1833647.0588235294
Depreciation & amortization: 3960082.3529411764
Net tangible assets: 716461871.7647059
Owner earnings: 28256968.23529412
Return on net tangible assets (%): 3.943959804266321
Capex to operating income (%): 26.395861859120647
Buffett classification: The Good
Stock price: 2.08
P/E ratio: 0.20340942402851073
Shares outstanding: 9662354
Book value: 837705522.3529412
P/B ratio: 0.02399136186132537
Market cap (USD): 20097696.32
Debt to equity: 0.006998521370054827
Current ratio: 5.605732970860953
Quick ratio: 5.605732970860953
Effective tax rate (%): -2.2261429577962306
Interest coverage ratio: 3.492832931211706
COGS to revenue (%): 67.78572127415083
SG&A to revenue (%): 21.84456944337842
Free cash flow (dilution-adjusted): 1352077.6470588236
Buyback yield (%): 0
Retained earnings: 267963130.5882353
Receivables turnover: 1.2939589369034563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1743694733742163
FCF margin (%): 5.482302058736163
Rule of 40 score: 5.482302058736163
Financial ratios for CTRM — annual report dated 2025-12-31
Total revenue: 96252241.1764706
Gross profit: 25550934.11764706
Operating income: -109274.11764705883
Net income: 25343721.17647059
Capital expenditures: 71819840
Operating cash flow: 11819236.470588235
Depreciation & amortization: 17364808.23529412
Net tangible assets: 659817123.5294118
Owner earnings: -29111310.58823529
Return on net tangible assets (%): -4.41202714359953
Buffett classification: The Gruesome
Stock price: 2.07
P/E ratio: 0.7891924252453201
Shares outstanding: 9662354
Book value: 787008797.6470588
P/B ratio: 0.025414039639452237
Market cap (USD): 20001072.779999997
Debt to equity: 0.11667085811394427
Current ratio: 6.435187368209589
Quick ratio: 6.4121748937364424
Effective tax rate (%): 3.864101050908888
Interest coverage ratio: -0.03053941357539618
COGS to revenue (%): 73.45419306050077
SG&A to revenue (%): 23.7486247073483
Free cash flow (dilution-adjusted): 10166752.941176472
Buyback yield (%): 352.9222460742311
Retained earnings: 281709152.9411765
Inventory turnover: 75.89924449473848
Receivables turnover: 2.236610447779147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.012174167754510992
FCF margin (%): 10.562614248676624
Revenue growth (%): 39.48888617141913
Rule of 40 score: 50.051500420095756
Financial ratios for CTRM — quarterly report dated 2025-12-31
Total revenue: 26547520
Gross profit: 6892488.235294118
Operating income: 1589370.5882352942
Net income: 20652784.70588235
Capital expenditures: 203527.05882352943
Operating cash flow: 14663572.94117647
Depreciation & amortization: 5577484.705882353
Net tangible assets: 659817123.5294118
Owner earnings: 26026742.352941174
Return on net tangible assets (%): 3.9445387857960035
Capex to operating income (%): 12.805513096194202
Buffett classification: The Great
Stock price: 2.07
P/E ratio: 0.8127739677368749
Shares outstanding: 9662354
Book value: 787008797.6470588
P/B ratio: 0.025414039639452237
Market cap (USD): 20001072.779999997
Debt to equity: 0.11667085811394427
Current ratio: 6.435187368209589
Quick ratio: 6.4121748937364424
Effective tax rate (%): 3.9448620179786156
Interest coverage ratio: 2.7904831936678556
COGS to revenue (%): 74.03716718061003
SG&A to revenue (%): 23.499436659465083
Free cash flow (dilution-adjusted): 14387430.588235294
Buyback yield (%): 0
Retained earnings: 281709152.9411765
Inventory turnover: 21.100063400809304
Receivables turnover: 0.6168839277805905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.17707087992929754
FCF margin (%): 54.195008001633646
Revenue growth (%): 7.642873814929308
Rule of 40 score: 61.837881816562955
Financial ratios for CYVIZ.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.5279361459521095
Shares outstanding: 13026123
Market cap (USD): 72007576.17331813
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYVIZ.OL — annual report dated 2022-12-31
Total revenue: 49186943.319838054
Gross profit: 22286943.319838054
Operating income: -1113360.3238866397
Net income: -1959412.9554655869
Capital expenditures: 3397874.4939271254
Operating cash flow: -8299.595141700403
Depreciation & amortization: 2029149.79757085
Net tangible assets: 4107388.663967611
Owner earnings: -3328137.651821862
Return on net tangible assets (%): -81.02806732214583
Buffett classification: The Gruesome
Stock price: 3.8967611336032384
Shares outstanding: 13026123
Book value: 9984615.384615386
P/B ratio: 5.083790198483496
Market cap (USD): 50759689.82793522
Debt to equity: 0.09123347660368177
Current ratio: 1.322500118710868
Quick ratio: 1.1357713153842504
Interest coverage ratio: -5.826271186440678
COGS to revenue (%): 54.689310179497774
Free cash flow (dilution-adjusted): -3546659.91902834
Buyback yield (%): 0
Inventory turnover: 9.65495695135685
Receivables turnover: 3.5625728507649788
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.784213616067456
FCF margin (%): -7.2105719112614635
Rule of 40 score: -7.2105719112614635
Financial ratios for CYVIZ.OL — annual report dated 2023-12-31
Total revenue: 57506679.76424362
Gross profit: 28377308.44793713
Operating income: 450884.0864440079
Net income: 363064.8330058939
Capital expenditures: 2704027.5049115913
Operating cash flow: -1116404.7151277014
Depreciation & amortization: 2285461.6895874264
Net tangible assets: 3895481.3359528487
Owner earnings: -55500.98231827095
Return on net tangible assets (%): -1.4247528747226101
Capex to operating income (%): 599.7167755991285
Buffett classification: The Gruesome
Stock price: 3.9292730844793713
P/E ratio: 140.97535714285715
Shares outstanding: 13026123
Book value: 9514734.774066798
P/B ratio: 5.379361139789386
Market cap (USD): 51183194.49901768
Debt to equity: 0.3453128226306008
Current ratio: 1.235398304727365
Quick ratio: 1.1072226807477514
Effective tax rate (%): 9.765625
Interest coverage ratio: 0.774814314652262
COGS to revenue (%): 50.65389174914334
Free cash flow (dilution-adjusted): -3917288.801571709
Buyback yield (%): 0
Retained earnings: -6530353.634577603
Inventory turnover: 13.9376292536191
Receivables turnover: 3.4326306839836995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.205800155770376
FCF margin (%): -6.811884841258724
Revenue growth (%): 16.914522194043418
Rule of 40 score: 10.102637352784694
Financial ratios for CYVIZ.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.9198473282442747
Shares outstanding: 13026123
Market cap (USD): 38034290.438931294
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYVIZ.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.7336860670194003
Shares outstanding: 13026123
Market cap (USD): 35609330.952380955
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYVIZ.OL — annual report dated 2024-12-31
Total revenue: 52527449.24977934
Gross profit: 27667166.813768756
Operating income: 406090.026478376
Net income: 941041.4827890556
Capital expenditures: 3162400.7060900265
Operating cash flow: 3195145.631067961
Depreciation & amortization: 2075639.894086496
Net tangible assets: 4178552.5154457195
Owner earnings: -145719.32921447512
Return on net tangible assets (%): -3.48731597068205
Capex to operating income (%): 778.7437513584003
Buffett classification: The Gruesome
Stock price: 2.7336860670194003
P/E ratio: 37.840341370331664
Shares outstanding: 13026123
Book value: 9766902.030008826
P/B ratio: 3.645918720487951
Market cap (USD): 35609330.952380955
Debt to equity: 0.4035189184792922
Current ratio: 1.1591644864634385
Quick ratio: 0.9847026062421368
Interest coverage ratio: 0.6573796256608088
COGS to revenue (%): 47.32817372835789
Free cash flow (dilution-adjusted): -59576.34598411298
Buyback yield (%): 0
Retained earnings: -5088702.559576346
Inventory turnover: 8.498793072234626
Receivables turnover: 5.70375978761944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.774374287331522
FCF margin (%): -0.11341945370469945
Revenue growth (%): -8.658525470218938
Rule of 40 score: -8.771944923923638
Financial ratios for CYVIZ.OL — quarterly report dated 2025-03-31
Total revenue: 12961545.801526718
Gross profit: 7018606.870229008
Operating income: -323473.2824427481
Net income: -1032061.0687022901
Capital expenditures: 798091.6030534351
Operating cash flow: -1677576.3358778625
Depreciation & amortization: 438645.03816793894
Net tangible assets: 3944274.809160305
Owner earnings: -1391507.6335877862
Return on net tangible assets (%): -35.27917553706212
Buffett classification: The Gruesome
Stock price: 2.709923664122137
Shares outstanding: 13026123
Book value: 10205248.091603052
P/B ratio: 3.458984892146871
Market cap (USD): 35299798.96946564
Debt to equity: 0.6488111378107733
Current ratio: 1.0973177824388898
Quick ratio: 0.9364069952305246
Interest coverage ratio: -1.527027027027027
COGS to revenue (%): 45.85054145777659
Free cash flow (dilution-adjusted): -2475667.9389312975
Buyback yield (%): 0
Retained earnings: -5951240.458015267
Inventory turnover: 1.7236874878919546
Receivables turnover: 0.7400988345801165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9030186255619785
FCF margin (%): -19.10009791146742
Rule of 40 score: -19.10009791146742
Financial ratios for CYVIZ.OL — quarterly report dated 2025-06-30
Total revenue: 12841906.653426018
Gross profit: 6826415.094339622
Operating income: -756107.2492552135
Net income: -1585898.7090367428
Capital expenditures: 807646.4746772592
Operating cash flow: 358391.2611717974
Depreciation & amortization: 498212.51241310826
Net tangible assets: 2088977.1598808342
Owner earnings: -1895332.6713008936
Return on net tangible assets (%): -90.73017683970336
Buffett classification: The Gruesome
Stock price: 3.426017874875869
Shares outstanding: 13026123
Book value: 9262661.37040715
P/B ratio: 4.81802458858215
Market cap (USD): 44627730.238331676
Debt to equity: 0.7348807290270705
Current ratio: 1.022343400955304
Quick ratio: 0.8513966328254118
Interest coverage ratio: -4.318774815655134
COGS to revenue (%): 46.84266691411869
Free cash flow (dilution-adjusted): -449255.21350546175
Buyback yield (%): 0
Retained earnings: -7267428.003972194
Inventory turnover: 1.6089243027888447
Receivables turnover: 0.7680493193642648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.377906976744189
FCF margin (%): -3.4983528975084672
Revenue growth (%): -0.9230314804474027
Rule of 40 score: -4.42138437795587
Financial ratios for CYVIZ.OL — quarterly report dated 2025-09-30
Total revenue: 9523547.094188377
Gross profit: 6935070.140280561
Operating income: -315030.0601202405
Net income: -295490.98196392786
Capital expenditures: 1152805.6112224448
Operating cash flow: 4515731.462925851
Depreciation & amortization: 548797.5951903807
Net tangible assets: 1363026.0521042084
Owner earnings: -899498.997995992
Return on net tangible assets (%): -65.99279570682938
Buffett classification: The Gruesome
Stock price: 3.697394789579158
Shares outstanding: 13026123
Book value: 9260120.240480963
P/B ratio: 5.20109005691655
Market cap (USD): 48162719.308617234
Debt to equity: 0.37142918975069245
Current ratio: 0.9890184650492563
Quick ratio: 0.7707376913063742
Interest coverage ratio: -1.415578568212517
COGS to revenue (%): 27.179756957230783
Free cash flow (dilution-adjusted): 3362925.851703407
Buyback yield (%): 0
Retained earnings: -7419038.076152304
Inventory turnover: 0.6339697653872584
Receivables turnover: 0.9656395094841863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.0787610532809753
FCF margin (%): 35.3116944605187
Revenue growth (%): -25.84008472256224
Rule of 40 score: 9.471609737956463
Financial ratios for CYVIZ.OL — quarterly report dated 2025-12-31
Total revenue: 20272636.815920398
Gross profit: 9018507.462686567
Operating income: 1541890.5472636814
Net income: 1301691.5422885572
Capital expenditures: 827263.6815920398
Operating cash flow: -591442.7860696517
Depreciation & amortization: 560895.5223880596
Net tangible assets: 1820995.0248756218
Owner earnings: 1035323.383084577
Return on net tangible assets (%): 56.85481667668434
Capex to operating income (%): 53.65255549819309
Buffett classification: The Good
Stock price: 3.7749003984063747
P/E ratio: 9.443926480450695
Shares outstanding: 13026123
Book value: 10043283.58208955
P/B ratio: 4.896039875851033
Market cap (USD): 49172316.90239044
Debt to equity: 0.5908555010650419
Current ratio: 1.0157600913523408
Quick ratio: 0.8548286237334831
Effective tax rate (%): 2.1833408105278904
Interest coverage ratio: 15.605236656596173
COGS to revenue (%): 55.513890252282316
Free cash flow (dilution-adjusted): -1418706.4676616914
Buyback yield (%): 0
Retained earnings: -7272039.800995024
Inventory turnover: 3.1846825285090805
Receivables turnover: 1.622909032977537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.027083785936709
FCF margin (%): -6.998134877785413
Revenue growth (%): 112.86855218358205
Rule of 40 score: 105.87041730579664
Financial ratios for CYVIZ.OL — annual report dated 2025-12-31
Total revenue: 56113432.83582089
Gross profit: 30064179.10447761
Operating income: 134129.35323383083
Net income: -1657213.9303482587
Capital expenditures: 4029552.2388059697
Operating cash flow: 2865472.63681592
Depreciation & amortization: 2062487.5621890547
Net tangible assets: 1820995.0248756218
Owner earnings: -3624278.606965174
Return on net tangible assets (%): -199.02737555324845
Capex to operating income (%): 3004.2284866468844
Buffett classification: The Gruesome
Stock price: 3.7749003984063747
Shares outstanding: 13026123
Book value: 10043283.58208955
P/B ratio: 4.896039875851033
Market cap (USD): 49172316.90239044
Debt to equity: 0.5908555010650419
Current ratio: 1.0157600913523408
Quick ratio: 0.8548286237334831
Interest coverage ratio: 0.20225056264066013
COGS to revenue (%): 46.42249175444196
Free cash flow (dilution-adjusted): -1571542.2885572137
Buyback yield (%): 0
Retained earnings: -7272039.800995024
Inventory turnover: 7.371392369421371
Receivables turnover: 4.4921140672295685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.220218697950612
FCF margin (%): -2.800652551689896
Revenue growth (%): 6.826875542708008
Rule of 40 score: 4.026222991018112
Financial ratios for DATAPATTNS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.168666754582619
Shares outstanding: 55983969
Market cap (USD): 513298355.3598839
Buyback yield (%): 0
Retained earnings: 32592641.434788343
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DATAPATTNS.NS — annual report dated 2023-03-31
Total revenue: 55231425.091352016
Gross profit: 34414129.11084044
Operating income: 20780755.176613886
Net income: 15102314.250913521
Capital expenditures: 4685749.086479903
Operating cash flow: -2099878.197320341
Depreciation & amortization: 1030450.6699147382
Net tangible assets: 141908647.9902558
Owner earnings: 11447015.834348354
Return on net tangible assets (%): 8.06646810921232
Capex to operating income (%): 22.548502432448274
Buffett classification: The Great
Stock price: 16.63495736906212
P/E ratio: 61.665445586232764
Shares outstanding: 55983969
Book value: 142153471.3763703
P/B ratio: 6.551306335672789
Market cap (USD): 931290937.6658953
Debt to equity: 0.00213352983514412
Current ratio: 9.755069708491762
Quick ratio: 8.226631812420786
Effective tax rate (%): 24.77704301401444
Interest coverage ratio: 112.24342105263158
COGS to revenue (%): 37.69103539530268
SG&A to revenue (%): 1.9296504576028228
Free cash flow (dilution-adjusted): -6909866.017052376
Buyback yield (%): 0
Retained earnings: 42993909.86601706
Inventory turnover: 0.8857735164550401
Receivables turnover: 1.1855521857352018
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.036601207304956
FCF margin (%): -12.510750909692359
Rule of 40 score: -12.510750909692359
Financial ratios for DATAPATTNS.NS — annual report dated 2024-03-31
Total revenue: 62333613.14306272
Gross profit: 42532677.77911021
Operating income: 24747571.651277132
Net income: 21787984.17076388
Capital expenditures: 5518647.319822521
Operating cash flow: 16714234.320661949
Depreciation & amortization: 1934284.686413239
Net tangible assets: 153673102.2904425
Owner earnings: 18203621.5373546
Return on net tangible assets (%): 11.84567843431033
Capex to operating income (%): 22.299752871056842
Buffett classification: The Great
Stock price: 28.90882917466411
P/E ratio: 74.28089646367452
Shares outstanding: 55983969
Book value: 158797217.89183354
P/B ratio: 10.191809515473395
Market cap (USD): 1618430996.340691
Debt to equity: 0.0026430853112421747
Current ratio: 4.000085662887982
Quick ratio: 3.238257045772537
Effective tax rate (%): 24.98038729922788
Interest coverage ratio: 529.1538461538462
COGS to revenue (%): 31.766063870719506
SG&A to revenue (%): 1.7468257021931513
Free cash flow (dilution-adjusted): 6257345.005396331
Buyback yield (%): 0
Retained earnings: 61096054.682815686
Inventory turnover: 0.6188905547226388
Receivables turnover: 1.3034756005817745
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.38283789021736
FCF margin (%): 10.038476337052712
Revenue growth (%): 12.85896215780017
Rule of 40 score: 22.89743849485288
Financial ratios for DATAPATTNS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 152882226.469183
Buffett classification: The Gruesome
Stock price: 27.577281414237937
Shares outstanding: 55983969
Book value: 161206402.29335883
P/B ratio: 9.577074147399268
Market cap (USD): 1543885667.7989728
Debt to equity: 0.004934722366295698
Current ratio: 4.358935118762952
Quick ratio: 3.3019607843137257
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DATAPATTNS.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.71325329292458
Shares outstanding: 55983969
Market cap (USD): 1607481882.2402377
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DATAPATTNS.NS — annual report dated 2025-03-31
Total revenue: 82809212.0645312
Gross profit: 50531914.89361702
Operating income: 30862754.267009582
Net income: 25930558.802899227
Capital expenditures: 4192190.7879354684
Operating cash flow: -10507364.975450082
Depreciation & amortization: 1627308.8613514144
Net tangible assets: 163161094.224924
Owner earnings: 23365676.876315173
Return on net tangible assets (%): 14.32061790668348
Capex to operating income (%): 13.583333333333334
Buffett classification: The Great
Stock price: 19.662621075971526
P/E ratio: 42.4515174217094
Shares outstanding: 55983969
Book value: 176317512.2749591
P/B ratio: 6.243234461357998
Market cap (USD): 1100791568.7759366
Debt to equity: 0.00409091511848404
Current ratio: 5.157162474703671
Quick ratio: 4.006143394044521
Effective tax rate (%): 24.89672919347193
Interest coverage ratio: 455.17241379310343
COGS to revenue (%): 38.9779064022023
SG&A to revenue (%): 1.5500811745605987
Free cash flow (dilution-adjusted): -22949497.311199438
Buyback yield (%): 0
Retained earnings: 81236848.25812484
Inventory turnover: 0.8668487645599823
Receivables turnover: 1.1877095908786048
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.897297712464315
FCF margin (%): -27.71370085409755
Revenue growth (%): 32.84840696539548
Rule of 40 score: 5.134706111297934
Financial ratios for DATAPATTNS.NS — quarterly report dated 2025-03-31
Total revenue: 46318681.318681315
Gross profit: 22666588.730418514
Operating income: 17022445.639466915
Net income: 13336450.783259293
Capital expenditures: 0
Depreciation & amortization: 453588.96422726207
Net tangible assets: 163161094.224924
Owner earnings: 13790039.747486556
Return on net tangible assets (%): 8.451794107531812
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.662621075971526
P/E ratio: 20.635017267069955
Shares outstanding: 55983969
Book value: 176317512.2749591
P/B ratio: 6.243234461357998
Market cap (USD): 1100791568.7759366
Debt to equity: 0.00409091511848404
Current ratio: 5.157162474703671
Quick ratio: 4.006143394044521
Effective tax rate (%): 25.491476716086474
Interest coverage ratio: 46.669871794871796
COGS to revenue (%): 51.06382978723405
Buyback yield (%): 0
Retained earnings: 81236848.25812484
Inventory turnover: 0.6352076857869454
Receivables turnover: 0.6643360160965794
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.319755757242156
Rule of 40 score: 0
Financial ratios for DATAPATTNS.NS — quarterly report dated 2025-06-30
Total revenue: 11622981.511818396
Gross profit: 9271003.97846946
Operating income: 3111397.144863094
Net income: 2983852.0945471567
Capital expenditures: 0
Depreciation & amortization: 642405.8038848585
Owner earnings: 3626257.8984320154
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 33.840627194008896
P/E ratio: 116.08440345468564
Shares outstanding: 55983969
Market cap (USD): 1894532623.769951
Effective tax rate (%): 24.889543446244478
Interest coverage ratio: 8.335423197492164
COGS to revenue (%): 20.235578375113256
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -74.90649305870761
Rule of 40 score: -74.90649305870761
Financial ratios for DATAPATTNS.NS — quarterly report dated 2025-09-30
Total revenue: 34662908.68094701
Gross profit: 13351747.463359639
Operating income: 7083427.282976325
Net income: 5576099.210822999
Capital expenditures: 0
Depreciation & amortization: 636978.579481398
Net tangible assets: 159447576.09921083
Owner earnings: 6213077.790304396
Return on net tangible assets (%): 3.8966273067948802
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 28.741826381059752
P/E ratio: 73.48611477847354
Shares outstanding: 55983969
Book value: 173374295.37767756
P/B ratio: 9.280969324866858
Market cap (USD): 1609081517.1206315
Debt to equity: 0.0037780508898903
Current ratio: 8.233002572583608
Quick ratio: 6.590530442239373
Effective tax rate (%): 25.76917304517485
Interest coverage ratio: 26.070539419087137
COGS to revenue (%): 61.481168282052955
Buyback yield (%): 0
Inventory turnover: 0.7049412642177886
Receivables turnover: 0.4604004132912056
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9538103328928327
Revenue growth (%): 198.22734077053573
Rule of 40 score: 198.22734077053573
Financial ratios for DATAPATTNS.NS — quarterly report dated 2025-12-31
Total revenue: 19285952.99097694
Gross profit: 14934833.463295087
Operating income: 8317923.5824885825
Net income: 6494374.512643422
Capital expenditures: 0
Depreciation & amortization: 659463.0722958673
Owner earnings: 7153837.584939289
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.259218001559542
P/E ratio: 57.696454611604786
Shares outstanding: 55983969
Market cap (USD): 1638047153.5635514
Effective tax rate (%): 22.54550285638369
Interest coverage ratio: 33.94090909090909
COGS to revenue (%): 22.56108126841102
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -44.361411881231554
Rule of 40 score: -44.361411881231554
Financial ratios for DHR.V — annual report dated 2021-09-30
Capital expenditures: 260967.96875
Buffett classification: The Gruesome
Stock price: 0.6640625
Shares outstanding: 16150929
Market cap (USD): 10725226.2890625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHR.V — annual report dated 2022-09-30
Total revenue: 0
Operating income: -226849.63503649633
Net income: -1788131.3868613138
Capital expenditures: 361056.93430656934
Operating cash flow: -184900
Net tangible assets: 218800.72992700728
Owner earnings: -2149188.321167883
Return on net tangible assets (%): -982.2582958863345
Buffett classification: The Gruesome
Stock price: 0.072992700729927
Shares outstanding: 16150929
Book value: 218800.72992700728
P/B ratio: 5.388007285901581
Market cap (USD): 1178899.9270072991
Debt to equity: 0.13344142088424957
Current ratio: 6.145495742927767
Quick ratio: 6.145495742927767
Free cash flow (dilution-adjusted): -720919.708029197
Buyback yield (%): 0
Retained earnings: -17781481.021897808
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -103.67864637022655
Rule of 40 score: 0
Financial ratios for DHR.V — annual report dated 2023-09-30
Total revenue: 0
Operating income: -178914.8148148148
Net income: 32521.481481481478
Capital expenditures: 8092.592592592592
Operating cash flow: -183204.44444444444
Net tangible assets: 254563.70370370368
Owner earnings: 24428.888888888887
Return on net tangible assets (%): 9.596375497947104
Buffett classification: The Gruesome
Stock price: 0.037037037037037035
P/E ratio: 18.393459593658893
Shares outstanding: 16150929
Book value: 254563.70370370365
P/B ratio: 2.3498344298596585
Market cap (USD): 598182.5555555555
Debt to equity: 0.11639377176927264
Current ratio: 1.9395525844189843
Quick ratio: 1.9395525844189843
Free cash flow (dilution-adjusted): -191297.03703703702
Buyback yield (%): 0
Retained earnings: -18012388.888888888
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -70.28292416072817
Rule of 40 score: 0
Financial ratios for DHR.V — annual report dated 2024-09-30
Total revenue: 0
Operating income: -266140.74074074073
Net income: -188813.3333333333
Capital expenditures: 0
Operating cash flow: -133998.5185185185
Net tangible assets: 289573.3333333333
Owner earnings: -188813.3333333333
Return on net tangible assets (%): -65.2039782668754
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 16150929
Book value: 289573.3333333333
P/B ratio: 3.305180341959051
Market cap (USD): 957092.0888888888
Debt to equity: 0
Current ratio: 1.452376272652227
Quick ratio: 1.452376272652227
Free cash flow (dilution-adjusted): -192568.88888888888
Buyback yield (%): 0
Retained earnings: -18201202.22222222
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -91.90789002465952
Rule of 40 score: 0
Financial ratios for DHR.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 16150929
Market cap (USD): 957092.0888888888
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHR.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -21440.559440559442
Net income: -21225.174825174825
Capital expenditures: 0
Operating cash flow: -17325.87412587413
Net tangible assets: 252148.25174825176
Owner earnings: -21225.174825174825
Return on net tangible assets (%): -8.41773626349245
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 16150929
Book value: 252148.2517482518
P/B ratio: 3.1354764929057164
Market cap (USD): 790604.9160839162
Debt to equity: 0
Current ratio: 1.0525718894125358
Quick ratio: 1.0525718894125358
Free cash flow (dilution-adjusted): -17325.87412587413
Buyback yield (%): 0
Retained earnings: -17204178.32167832
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.503156096424568
Rule of 40 score: 0
Financial ratios for DHR.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -52890.909090909096
Net income: -52908.39160839161
Capital expenditures: 0
Operating cash flow: -22993.706293706295
Net tangible assets: 223365.73426573427
Owner earnings: -52908.39160839161
Return on net tangible assets (%): -23.68688813542342
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 16150929
Book value: 223365.73426573427
P/B ratio: 3.539508504663242
Market cap (USD): 790604.9160839162
Debt to equity: 0
Current ratio: 0.5881134533792136
Quick ratio: 0.5881134533792136
Free cash flow (dilution-adjusted): -22993.706293706295
Buyback yield (%): 0
Retained earnings: -17257086.713286713
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.67906127803189
Rule of 40 score: 0
Financial ratios for DHR.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -34969.34306569343
Net income: -35133.57664233576
Capital expenditures: 0
Operating cash flow: -12832.846715328466
Net tangible assets: 198014.59854014596
Owner earnings: -35133.57664233576
Return on net tangible assets (%): -17.742922441757596
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
Shares outstanding: 16150929
Book value: 198014.59854014596
P/B ratio: 3.5721606458271897
Market cap (USD): 707339.9562043794
Debt to equity: 0
Current ratio: 0.2641515958366472
Quick ratio: 0.2641515958366472
Free cash flow (dilution-adjusted): -12832.846715328466
Buyback yield (%): 0
Retained earnings: -18048005.10948905
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.659982306104396
Rule of 40 score: 0
Financial ratios for DHR.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -42220.14388489209
Net income: 256886.3309352518
Capital expenditures: 0
Operating cash flow: -12120.863309352519
Net tangible assets: 452051.79856115114
Owner earnings: 256886.3309352518
Return on net tangible assets (%): 56.82674679160725
Buffett classification: The Gruesome
Stock price: 0.05035971223021583
P/E ratio: 5.509826659293145
Shares outstanding: 16150929
Book value: 452051.79856115114
P/B ratio: 1.7992542874057853
Market cap (USD): 813356.1366906476
Debt to equity: 0
Current ratio: 0.10010072005455148
Quick ratio: 0.10010072005455148
Free cash flow (dilution-adjusted): -12120.863309352519
Buyback yield (%): 0
Retained earnings: -17531435.251798563
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.339669484620085
Rule of 40 score: 0
Financial ratios for DHR.V — annual report dated 2025-09-30
Total revenue: 0
Operating income: -153156.8345323741
Net income: 145991.36690647484
Capital expenditures: 0
Operating cash flow: -66248.92086330935
Net tangible assets: 452051.79856115114
Owner earnings: 145991.36690647484
Return on net tangible assets (%): 32.29527398655531
Buffett classification: The Gruesome
Stock price: 0.05035971223021583
P/E ratio: 5.5712618761334065
Shares outstanding: 16150929
Book value: 452051.79856115114
P/B ratio: 1.7992542874057853
Market cap (USD): 813356.1366906476
Debt to equity: 0
Current ratio: 0.10010072005455148
Quick ratio: 0.10010072005455148
Free cash flow (dilution-adjusted): -91069.06474820143
Buyback yield (%): 0
Retained earnings: -17531435.251798563
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.88037278468119
Rule of 40 score: 0
Financial ratios for DHR.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -23846.71532846715
Net income: -24167.15328467153
Capital expenditures: 0
Operating cash flow: -29021.167883211678
Net tangible assets: 512710.21897810214
Owner earnings: -24167.15328467153
Return on net tangible assets (%): -4.713608660431968
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
P/E ratio: 7.333635606519017
Shares outstanding: 16150929
Book value: 512710.21897810214
P/B ratio: 2.0694144470560767
Market cap (USD): 1061009.9343065692
Debt to equity: 0
Current ratio: 0.5764812263698651
Quick ratio: 0.5764812263698651
Free cash flow (dilution-adjusted): -29021.167883211678
Buyback yield (%): 0
Retained earnings: -17811535.766423356
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.651109817158851
Rule of 40 score: 0
Financial ratios for DLHC — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.3
Shares outstanding: 14493035
Market cap (USD): 178264330.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLHC — annual report dated 2022-09-30
Total revenue: 395173000
Gross profit: 72287000
Operating income: 33278000
Net income: 23288000
Capital expenditures: 872000
Operating cash flow: 1243000
Depreciation & amortization: 7665000
Net tangible assets: -14467000
Owner earnings: 30081000
Return on net tangible assets (%): -207.92838874680308
Capex to operating income (%): 2.6203497806358556
Buffett classification: The Great
Stock price: 12.27
P/E ratio: 7.636101831415321
Shares outstanding: 14493035
Book value: 92060000
P/B ratio: 1.931669991853139
Market cap (USD): 177829539.45
Debt to equity: 0.4248533565066261
Current ratio: 1.131314703821904
Quick ratio: 1.131314703821904
Effective tax rate (%): 25.029778192705148
Interest coverage ratio: 21.142312579415503
COGS to revenue (%): 81.70750532045459
SG&A to revenue (%): 7.776340994956639
Free cash flow (dilution-adjusted): -2237000
Buyback yield (%): 0
Retained earnings: 990000
Receivables turnover: 9.535797881325257
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.506051153129818
FCF margin (%): -0.5660811846963228
Rule of 40 score: -0.5660811846963228
Financial ratios for DLHC — annual report dated 2023-09-30
Total revenue: 375872000
Gross profit: 79856000
Operating income: 24764000
Net income: 1461000
Capital expenditures: 625000
Operating cash flow: 31033000
Depreciation & amortization: 15562000
Net tangible assets: -160499000
Owner earnings: 16398000
Return on net tangible assets (%): -10.216886086517674
Capex to operating income (%): 2.5238249071232435
Buffett classification: The Great
Stock price: 11.67
P/E ratio: 115.76572104722793
Shares outstanding: 14493035
Book value: 102439000
P/B ratio: 1.6510676446470582
Market cap (USD): 169133718.45
Debt to equity: 1.8714161598609904
Current ratio: 0.9631716239369009
Quick ratio: 0.9631716239369009
Effective tax rate (%): -78.17073170731707
Interest coverage ratio: 1.7497350385077368
COGS to revenue (%): 78.75446960667462
SG&A to revenue (%): 10.055284777796697
Free cash flow (dilution-adjusted): 28486000
Buyback yield (%): 0
Retained earnings: 2451000
Receivables turnover: 6.252757307071682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.003322983850444
FCF margin (%): 7.5786437936318745
Revenue growth (%): -4.884189962370911
Rule of 40 score: 2.6944538312609634
Financial ratios for DLHC — quarterly report dated 2024-09-30
Capital expenditures: 209000
Buffett classification: The Gruesome
Stock price: 9.36
Shares outstanding: 14493035
Market cap (USD): 135654807.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLHC — annual report dated 2024-09-30
Total revenue: 395937000
Gross profit: 77490000
Operating income: 24900000
Net income: 7397000
Capital expenditures: 836000
Operating cash flow: 27366000
Depreciation & amortization: 17052000
Net tangible assets: -136350000
Owner earnings: 23613000
Return on net tangible assets (%): -17.317931793179316
Capex to operating income (%): 3.357429718875502
Buffett classification: The Great
Stock price: 9.36
P/E ratio: 18.33916555360281
Shares outstanding: 14493035
Book value: 110132000
P/B ratio: 1.2317474267242943
Market cap (USD): 135654807.6
Debt to equity: 1.496522354992191
Current ratio: 0.9946470831298598
Quick ratio: 0.9946470831298598
Effective tax rate (%): 4.517877888214793
Interest coverage ratio: 1.6219385096404377
COGS to revenue (%): 80.4287045666356
SG&A to revenue (%): 8.975670371801575
Free cash flow (dilution-adjusted): 24632000
Buyback yield (%): 0
Retained earnings: 9848000
Receivables turnover: 7.800945719633534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.535151777405902
FCF margin (%): 6.221191755253992
Revenue growth (%): 5.338253447982292
Rule of 40 score: 11.559445203236283
Financial ratios for DLHC — quarterly report dated 2024-12-31
Capital expenditures: 552000
Buffett classification: The Gruesome
Stock price: 8.03
Shares outstanding: 14493035
Market cap (USD): 116379071.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0